K. Lindor

Publications714
h-index108
Citations45,325
Highly Influential Citations1,655
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Hirschfield
  • 548 Publications • 25,181 Citations
  • M. Gershwin
  • 875 Publications • 35,602 Citations
  • A. Parés
  • 450 Publications • 17,275 Citations
  • N. LaRusso
  • 584 Publications • 34,595 Citations
  • Publications
  • Influence
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
TLDR
A simple scoring system accurately separates patients with nonalcoholic fatty liver disease with and without advanced fibrosis, rendering liver biopsy for identification ofAdvanced fibrosis unnecessary in a substantial proportion of patients.
View on Wiley
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
TLDR
Mortality among community-diagnosed NAFLD patients is higher than the general population and is associated with older age, impaired fasting glucose, and cirrhosis, although the absolute risk is low.
View on PubMed
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
TLDR
IAC should be suspected in unexplained biliary strictures associated with increased serum IgG4 and unexplained pancreatic disease, especially with proximal strictures, and the role of immunomodulatory drugs for relapses needs further study.
View on PubMed
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
TLDR
Older age, obesity, and presence of diabetes mellitus help identify those NASH patients who might have severe liver fibrosis, and this is the subgroup of patients who would be expected to derive the most benefit from having a liver biopsy and considering investigational therapies.
View on Wiley
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
View on PubMed
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
TLDR
In a systematic review and meta-analysis, Giovanni Musso and colleagues examine the association between non-alcoholic fatty liver disease and chronic kidney disease and finds no clear link between the two.
View PDF
Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview‐based study of 1032 patients
TLDR
Environmental factors, possibly including infectious agents through urinary tract infections or chemicals contained in cigarette smoke, may induce PBC in genetically susceptible individuals and exogenous estrogens may also contribute to explain the female predominance of the disease.
View on Wiley
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
View on PubMed
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
TLDR
Current understanding of this enigmatic disorder is reviewed, the recognition of specific clinical subtypes and their pattern of progression could improve phenotypic and genotypic classification of the disease, and important topics for future studies are discussed.
View on PubMed
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
TLDR
UDCA significantly decreases the risk of developing colorectal dysplasia or cancer in patients with UC and PSC in a randomized, placebo-controlled trial.
View on PubMed
...
...